Sanara–MiMedx deal spread jumps after FTC requests more information
Sanara MedTech and MiMedx both received second requests from the FTC, pushing the deal spread to $1.98 from 13 cents, according to Seeking Alpha reporting.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Sanara MedTech and MiMedx have each disclosed that they received a second request from the Federal Trade Commission tied to their planned merger. Seeking Alpha reports the requests came on Thursday, and the spread on the deal widened to $1.98 from 13 cents over the same day.
A second request pushes the HSR Act waiting period out until 30 days after the parties have substantially complied with the agency's demands. Sanara says it is still working “constructively” with the FTC on its review. Under the terms, Sanara holders would receive $33.00 in cash plus 0.4735 MiMedx shares for each Sanara share they own.
why it matters
For merger-arbitrage investors, a longer review means more time before the deal closes and more uncertainty about whether it closes at all, which is why the spread widened so sharply. The move is limited to the two companies' shares and the spread on their deal.
market impact
Sanara and MiMedx shares: longer FTC review widens the deal spread and raises timing risk for merger-arbitrage holders
tags
instruments
sources
- Sanara MedTech/MiMedx deal spread widens on FTC second request — seekingalpha.com, 16 October 2026 at 16:08 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗